pas4cii的部落格

A patentable creativeness is an creativity that is "novel" underneath 35 U.S.C.A. § 102, "useful" under 35 U.S.C.A. § 101, and "nonobvious" lower than 35 U.S.C.A. § 103. Section 103(a) of the Patent Act sets away the parametric quantity of the noticeability requirement:

A government grant may not be obtained on the other hand the innovation is not identically disclosed or represented as set off in Section 102 of this title, if the differences concerning the taxable entity wanted to be patented and the antecedent art essential not be specified that the thesis event as a together would have been observable at the clip the invention was made to a mortal having average neatness in the art to which said problem situation pertains.

In Graham v. John Deere Co., 383 U.S. 1, 17 (1966), the United States Supreme Court understood this verbal skill to expect that the final strength of mind on the content of noticeability is burned as a interrogate of law but is supported on factual inquires that consider (1) the breadth and smug of the antecedent art; (2) the differences linking the anterior art and the claimed invention; (3) the even of precision in the art; and (4) the object confirmation of non-obviousness.

To get your hands on a unobstructed on a new natural science compound, the bipartite essential unite the nonobviousness design at the instance it is fabricated. Special issues, however, originate with chemical patents because disparate electrical and mechanic sciences, chemical science is an difficult art. Minor changes in structures can dramatically feeling a compound's properties. Thus, it is inherently bad-tempered for a trial to establish the conspicuousness of a claimed combined with a associated artefact to that of a preceding art.

The degree of the face to determine the conspicuousness of chemical compounds can be illustrated by the issues moon-faced by the board in Yamanouchi Pharmaceutical Co. v. Danbury Pharmacal, 231 F.3d 1339 (Fed. Cir. 2000). In Yamanouchi, the dispute central on whether one virtuoso in the art would have reasoned it evident to brand the linctus Famotidine by (1) combining the polar outgrowth from atomic number 82 paripinnate 44 next to the adapted heterocycle from Tiotidine to be an grey compound, and (2) substituting the carbamoyl bunch in the gray complex beside a sulfamoyl contingent to craft Famotidine as shown below in Scheme 1. It was fine celebrated that some Tiotidine and Tagamet were preceding compounds, of which Tagamet was a productive tablets in marketplace plonk patch Tiotidine inferior in presymptomatic trials due to its glorious toxicity. Both compounds, however, showed exalted effectuality as inhibitors of internal organ tart organic process.

The tribunal in Yamanouchi upheld the unobstructed opposed to an assertion of noticeability. Id. at 1345. The board explained, "For a chemical compound, a star facie shield of conspicuousness requires a viewing of 'structural correlation relating claimed and anterior art field matter ... where the anterior art gives basis or motive to clear the claimed compositions.'" Id. at 1343 (quoting In re Dillon, 919 F.3d 688, 692 (Fed. Cir. 1990)). Even then again the claimed decompound substandard the examination of structural similarity, the Yamanouchi hearing nullified a prima facie grip of noticeability based on a drought of need to unite the anterior art to take home the claimed conception with twin natural manoeuvre to that of the antecedent art.

A. Structural similarity

Structural similarity relating chemical compounds has effectively created a extremely rare and unsettling strip of patent law. In re Jones, 958 F.2d 347, 350 (Fed. Cir. 1992). In seminal the noticeability of a orthodox chemical compound, courts previously focused on the correlation relating the structures of a claimed combined and that of a complex unveiled in the prior art. In re Hass, 141 F.2d 122 (C.C.P.A 1944); In re Henze, 181 F.2d 196 (C.C.P.A. 1950).

In Hass, the claimed quinquefoliate was a homolog of a antecedent art multipart (Scheme 2). See Hass, 141 F.2d at 125. There was with the sole purpose one more chemical element definite quantity in the claimed incised than that in the anterior art. The Court of Claims and Patent Appeals command that the claimed bipartite was not patentable unless it revealed "some nonobvious or unanticipated profitable properties not controlled by the homologous tripinnatifid unveiled in the preceding art." Id. The at-large rule astern the court's judgement was that natural science and somatic properties alter solitary somewhat involving members of a homologous order. Id. The Henze crust changed this principle into a presumption that was rebuttable if the claimant showed "that the claimed trilobed possesses unobvious or unpredicted gainful properties not in reality controlled by the prior art homologues." In re Henze, 181 F.2d at 201. Clearly both courts perceived chemic construction and chemic properties as two not like considerations. Therefore, for structurally analogous natural science homologues, a new bipinnate was deemed major facie deliberate because a scientist could judge or anticipate that the new natural science pinnated would have the same properties in a fixed policy as did a comparable prior art bilobed.

B. Inseparable framework and its properties

After unit 103 was enacted, courts leisurely captive to a more holistic view of chemic compounds that well thought out chemical properties in ornament to chemical structures. In re Papesch, 315 F.2d 381 (C.C.P.A. 1971). In ­Papesch, an someone claimed a home of compounds as well as messenger amalgamated 2,4,6-triethylpyrazolo(4,3-d)-4,5,6,7-tetrahydropyrimidine-5,7-dione (ethyl = CH2CH3), which was admittedly "structurally obvious" in desk light of a claimed palmate 2,4,6-trimethylpyrazolo(4,3-d)-4,5,6.7-tetrahydropyrimidine-5,7-dione (methyl = CH3) as shown in Scheme 3. Id. at 384.

Comparative tests of the trimethyl trilobate and the applicant's triethyl decompound showed that the last mentioned was an moving anti-inflammatory drug agent while the antecedent art bilobed was absolutely unoccupied for that utility-grade. The Papesch court declared that the properties of compounds were applicable to obviousness, accentuation that the design as a full was a conjugate near its own properties. Id. at 390. Additionally, the board found that verification of non-obvious or unexpectedly discriminatory properties not common by the anterior art bilobed may renounce a stellar facie baggage of patency. Id. at 391.

A tripinnated and all of its properties are inseparable; they are one and the aforesaid situation .... But a way is not a incised and piece it may tennis stroke in a charge to individuality what is being patented, as the metes and boundary of a action determine a scheme of land, the thing that is patented is not the technique but the imparipinnate known by it. And the patentability of the thing does not be on the identicalness of its instructions to that of another smooth but of the analogy of the ex decompound to the latter. There is no idea in law for ignoring any goods in production such a scrutiny. Id.

Thus the board liberally bucked up natural science official document applications as durable as a claimed design could demonstrate new properties even then again the claimed trilobed collective a analogous artifact next to a prior art multiple. The Papesch court, however, did not treaty next to the requirements for establishing a starring facie proceeding of noticeability. The hearing solitary control that, for cases next to a precondition of obviousness, an superintendent had to muse some the properties of the creativeness and the cognition likeness. Id.